Home Compliance Genetworx Laboratories Pays $1.4 Million to Settle Allegations of Fraudulent Billing for... ComplianceNews Genetworx Laboratories Pays $1.4 Million to Settle Allegations of Fraudulent Billing for Genetic Testing July 16, 2021 133 Share FacebookLinkedinTwitter karen roach | Shutterstock You must be a Paid or Free Trial Member to Access this Content. Paid members, please login to view your news subscription(s). RELATED ARTICLESMORE FROM AUTHOR Compliance Second Circuit Defines “Willfulness” Standard Under Anti-Kickback Statute Compliance A Guide for Whistleblowers Under the False Claims Act Compliance DOJ Plans to Apply the New Whistleblower Rewards Pilot Program to FCPA Cases